Zobrazeno 1 - 10
of 8 315
pro vyhledávání: '"Aster, JC"'
Autor:
Rogers JM; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Mimoso CA; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Martin BJE; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Martin AP; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA.; Ludwig Center at Harvard, Boston, Massachusetts 02115, USA., Adelman K; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA; stephen_blacklow@hms.harvard.edu karen_adelman@hms.harvard.edu.; Ludwig Center at Harvard, Boston, Massachusetts 02115, USA.; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts 02142, USA., Blacklow SC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA; stephen_blacklow@hms.harvard.edu karen_adelman@hms.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Publikováno v:
Genes & development [Genes Dev] 2024 Nov 27; Vol. 38 (21-24), pp. 965-978. Date of Electronic Publication: 2024 Nov 27.
Autor:
Tothova Z, Krill-Burger JM, Popova KD, Landers CC, Sievers QL, Yudovich D, Belizaire R, Aster JC, Morgan EA, Tsherniak A, Ebert BL
Publikováno v:
Cell stem cell [Cell Stem Cell] 2024 Oct 03; Vol. 31 (10), pp. 1548-1549. Date of Electronic Publication: 2024 Sep 24.
Autor:
Cao R; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Gozlan O; George S. Wise Faculty of Life Sciences, School of Neurobiology, Biochemistry, and Biophysics, Tel Aviv University, Tel Aviv 69978, Israel., Airich A; Institute of Genetics, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany., Tveriakhina L; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Zhou H; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Jiang H; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Cole PA; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Aster JC; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Klein T; Institute of Genetics, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany., Sprinzak D; George S. Wise Faculty of Life Sciences, School of Neurobiology, Biochemistry, and Biophysics, Tel Aviv University, Tel Aviv 69978, Israel., Blacklow SC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: stephen_blacklow@hms.harvard.edu.
Publikováno v:
Structure (London, England : 1993) [Structure] 2024 Oct 03; Vol. 32 (10), pp. 1667-1676.e5. Date of Electronic Publication: 2024 Aug 08.
Autor:
Cao R; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Jones DT; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Pan L; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Yang A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Wang S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Padi SKR; Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT, USA., Rawson S; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Blacklow SC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.
Autor:
Tveriakhina L; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Scanavachi G; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA., Egan ED; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Da Cunha Correia RB; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA., Martin AP; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Rogers JM; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Yodh JS; Department of Physics, Harvard University, Cambridge, MA 02138, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Kirchhausen T; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: kirchhausen@crystal.harvard.edu., Blacklow SC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: stephen_blacklow@hms.harvard.edu.
Publikováno v:
Developmental cell [Dev Cell] 2024 Jun 03; Vol. 59 (11), pp. 1425-1438.e8. Date of Electronic Publication: 2024 Apr 03.
Autor:
AlJabban A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Paik H; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Enterprise Research IS (ERIS), Digital, Mass General Brigham, Boston, MA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Berliner N; Harvard Medical School, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Brouillard J; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Brown JR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Burns KH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA., Castillo JJ; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Card J; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA., Dal Cin P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., DeAngelo DJ; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Ebert BL; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Garcia JS; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jacobson CA; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lakhani H; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA., Laubach JP; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA., Lindeman NI; Department of Pathology, Weill Cornell Medicine, New York, NY., Lindsley RC; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Luskin MR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Nowak A; Department of Performance Improvement, Stanford Medicine Children's Health, Stanford, CA., Petrides A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Enterprise Research IS (ERIS), Digital, Mass General Brigham, Boston, MA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Steensma DP; Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA., Stone RM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Weinberg OK; Department of Pathology, UT Southwestern Medical Center, Dallas, TX., Winer ES; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Feb; Vol. 20 (2), pp. 220-227. Date of Electronic Publication: 2023 Sep 08.
Autor:
Patel K; The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK., Manzo M; Institute of Medical Genetics and Pathology, University Hospital Basel, Schönbeinstrasse 40, 4056 Basel, Switzerland., Hapuarachi B; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Rack S; The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK., Jermann P; Institute of Medical Genetics and Pathology, University Hospital Basel, Schönbeinstrasse 40, 4056 Basel, Switzerland., Feeney L; Northern Ireland Cancer Centre, Belfast, UK., Heathcote E; The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK., Betts G; Manchester University NHS Foundation Trust, Manchester, UK., Aster JC; Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA., Murone M; Avrion Therapeutics AG, Rue de Bourg 27, 1003 Lausanne, Switzerland., Bobadilla M; Cellestia Biotech AG, Basel, Switzerland., Lehal R; Cellestia Biotech AG, Basel, Switzerland., Vogl FD; Cellestia Biotech AG, Basel, Switzerland., Harrington K; The Royal Marsden NHS Foundation Trust, Clyde Road, Wallington, London SM6, UK., Metcalf R; The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. Electronic address: robert.metcalf1@nhs.net.
Publikováno v:
Oral oncology [Oral Oncol] 2023 Nov; Vol. 146, pp. 106542. Date of Electronic Publication: 2023 Aug 22.
Autor:
Tveriakhina L, Scanavachi G, Egan ED, Correia RBDC, Martin AP, Rogers JM, Yodh JS, Aster JC, Kirchhausen T, Blacklow SC
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 28. Date of Electronic Publication: 2023 Sep 28.
Autor:
Brandstadter JD; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., De Martin A; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Lϋtge M; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Ferreira A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Gaudette BT; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Stanossek Y; Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland., Wang S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Gonzalez MV; Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Camiolo E; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Wertheim G; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Austin B; Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Allman D; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bagg A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lim MS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fajgenbaum DC; Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ludewig B; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Maillard I; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
European journal of immunology [Eur J Immunol] 2023 Sep; Vol. 53 (9), pp. e2250362. Date of Electronic Publication: 2023 Jun 27.
Autor:
Martin AP; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Bradshaw GA; Department of Systems Biology, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Eisert RJ; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Egan ED; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Tveriakhina L; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Rogers JM; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Dates AN; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Scanavachi G; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Kirchhausen T; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., Kalocsay M; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Blacklow SC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
Publikováno v:
Science signaling [Sci Signal] 2023 Aug; Vol. 16 (796), pp. eadg6474. Date of Electronic Publication: 2023 Aug 01.